The issue is they are spending lots of $$ on direct sales force but not getting sales traction. I agree, hard to know what to do. Think i'll put it down as another investor lesson.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game